Prediction Sciences, LLC

3252 Holiday Ct, Ste 209
La Jolla, CA 92037
http://www.predict.net/Prediction_Sciences/Home.html

SBIR Award Summary

Total Number of Awards 16
Total Value of Awards $4.95MM
First Award Date 01/01/01
Most Recent Award Date 09/01/10

Key Personnel

Last Name Name Awards Contact
Herold Christopher D Herold 2 Message
Bremer Troy M Bremer 2
Linke Steven P Linke 5 Message
Man Albert K Man 7 Message
Tang Sharon Tang 1 Message
Diamond Cornelius Diamond 1 Message

16 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 09/01/10 - 08/31/11

DESCRIPTION (provided by applicant): Stroke is the leading cause of disability and the third leading cause of death in the U.S., with an estimated $60 billion negative impact upon the economy in indirect and direct costs in 2006. Immediate treatment of stroke is critical for preservation brain tissue and ultimate recovery. For ischemic stroke, w...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 09/30/09 - 08/31/10

DESCRIPTION (provided by applicant): Stroke is the leading cause of disability and the third leading cause of death in the U.S., with an estimated $60 billion negative impact upon the economy in indirect and direct costs in 2006. Immediate treatment of stroke is critical for preservation brain tissue and ultimate recovery. For ischemic stroke, w...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 08/01/08 - 07/31/10

DESCRIPTION (provided by applicant): With a projected 55,170 deaths in the United States in 2006, colorectal cancer is second only to lung cancer as the most deadly. Patients with operable, but somewhat advanced, disease (stages II-III) are either observed only or treated with adjuvant therapy to reduce the chances of recurrence after surgery. A...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 03/01/08 - 02/28/10

DESCRIPTION (provided by applicant): In the United States (US), stroke affects more than 700,000 people annually in the U.S. and is the third leading cause of death. Stroke patients may present to the emergency room with a wide variety of symptoms that can be caused by other conditions not related to stroke, collectively called stroke mimic. Eve...

Phase 2 SBIR

Agency: National Science Foundation
Topic: 2008
Budget: 01/01/08 - 12/31/08

This Small Bbusiness Innovation Research (SBIR) Phase II project aims to continue the validation of a set of markers for predicting recurrence and guiding the selection of treatment in stage I-III breast cancer patients. Upon removal of their primary stage I-III operable tumors, breast cancer patients must decide whether or not to receive adju...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-16
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): Several effective medication treatments are now available for patients with bipolar disorder. Lithium is the first mood stabilizer and the one for which there is the greatest efficacy data. Many patients tolerate this medication well, respond well and are stabilized on it. Others do not respond or tolerate th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 08/01/07 - 07/31/08

DESCRIPTION (provided by applicant): With a projected 55,170 deaths in the United States in 2006, colorectal cancer is second only to lung cancer as the most deadly. Patients with operable, but somewhat advanced, disease (stages II-III) are either observed only or treated with adjuvant therapy to reduce the chances of recurrence after surgery. A...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 04/01/07 - 03/31/09

DESCRIPTION (provided by applicant): Currently there is only one approved drug treatment for acute ischemic stroke, t-PA. t-PA is a highly beneficial treatment but is severely underutilized due largely to fear of an often fatal side effect called hemorrhagic transformation. There is a critical clinical need for a diagnostic to identify patients ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-16
Budget: 09/01/06 - 08/31/07

DESCRIPTION (provided by applicant): Several effective medication treatments are now available for patients with bipolar disorder. Lithium is the first mood stabilizer and the one for which there is the greatest efficacy data. Many patients tolerate this medication well, respond well and are stabilized on it. Others do not respond or tolerate th...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 2006
Budget: 01/01/06 - 12/31/06

This Small Business Innovative Research Phase I project will develop a multiple biomarker test to predict adjuvant treatment outcomes in patients with operable breast cancer. The broader impact of this test will be improved clinical detection while helping to reveal previously hidden significance of individual biomarkers and biological pathways...

Load More